RYAN WAUGH: Open Payments
NPI 1992319248 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,507 in 146 payments from 15 companies in 2025. Trend: 2023 $161 · 2024 $1,172 · 2025 $2,507
Food & beverage: $2,507
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 27 | $529 |
| E.R. Squibb & Sons, L.L.C. | 19 | $400 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $288 |
| Otsuka America Pharmaceutical, Inc. | 20 | $232 |
| Axsome Therapeutics, Inc. | 9 | $227 |
| Janssen Pharmaceuticals, Inc | 8 | $185 |
| Neurocrine BioSciences, Inc. | 14 | $174 |
| Lundbeck LLC | 10 | $151 |
| Teva Pharmaceuticals USA, Inc. | 8 | $145 |
| ABBVIE INC. | 3 | $64 |
Products named: ARISTADA, COBENFY, REXULTI, CAPLYTA, Auvelity, INGREZZA, INVEGA SUSTENNA, SPRAVATO.
Industry payments across MI — which companies pay providers there.
